Table 1.

Details for pancreatic surgery and pathologic features (n = 30).

Variables	PDAC Group (n = 22) n (%)	IPMN (n = 8) n (%)
Procedures
Whipple	20 (91)	7 (87)
Left pancreatectomy	2 (9)	1 (13)
Vascular reconstruction	4 (18)	0 (0)
Post-operative complications
Dindo-Clavien III–IV	3 (13)	2 (25)
Dindo-Clavien V	0 (0)	0 (0)
Pathology: Macroscopic
Tumor size (mm) mean (med; range)	31 (30; 11–49)	In situ carcinoma n = 0 (0) High grade dysplasia n = 6 (75) Low grade dysplasia n = 2 (25)
Tumor stage
Stage 1a	1 (4.5)
Stage 1b	4 (18)
Stage 2b	11 (50)
Stage 3	6 (27.5)
Nodes status
Positive	17 (77.5)
Negative	5 (22.5)
Glandular Differentiation
Well	3 (13.5)
Moderately	11 (50)
Poorly	8 (36.5)
KRAS status: all primary tumors were positive for KRAS mean mutant allele frequency (med; range)	26.15 (17.45; 0.35–77.6)

Abbreviations: PDAC, Pancreatic ductal andenocarcinoma; med, median; IPMN, intraductal papillary and mucinous neoplasm. Note that Whipple surgery was performed for patients bearing tumors in the head of the pancreas, while left pancreatectomies were performed for patients with tumors in the tail of the pancreas.